Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)

被引:0
|
作者
Belani, C. P.
Ramalingam, S.
Schreeder, M.
Steis, R.
Guidice, R.
Marshland, T.
Butler, B.
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[2] Clearview Canc Inst, Huntsville, AL USA
[3] Atlanta Canc Care, Roswell, GA USA
[4] New Mexico Oncol Hematol Consultants, Albuquerque, NM USA
[5] Integrated Community Oncol Network, Orange Pk, FL USA
[6] Int Oncol Network, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7643
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)
    William, W. N., Jr.
    Kies, M. S.
    Fossella, F. V.
    Gladish, G.
    Heymach, J. V.
    Glisson, B. S.
    Tse, W. H.
    Liu, D.
    Herbst, R. S.
    Lippman, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    [J]. ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [3] Phase II study of Docetaxel (D) and Carboplatin (C) combination in advanced Non-Small Cell Lung Cancer (NSCLC)
    Chowdhury, Qamruzzaman
    Begum, Ferdous A.
    Nahar, Ferdous
    Fairuz, Saima
    Faruqui, Mesba
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S673 - S673
  • [4] Phase II study of combination of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Mitsuoka, Shigeki
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Yoshimura, Naruo
    Hirata, Kazuto
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 227 - 227
  • [5] Phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, Hye Jin
    Kim, Tae Gyoon
    Park, Won Hyoung
    Song, Dae Geun
    Min, Bo Young
    Park, Hyoun Kyoung
    Lee, Hyun Jung
    Nam, Seung-Hyun
    Kim, Bong-Seog
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S689 - S689
  • [6] Phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, B.
    Kim, H.
    Kim, T.
    Lee, H.
    Lee, B.
    Kim, J.
    Nam, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, Hye Jin
    Kim, Tae Gyoon
    Lee, Hyun Jeong
    Kim, Jee Ho
    Lim, Byung Hoon
    Seo, Jae Won
    Kang, Eun Mi
    Lee, Byung Uk
    Ahn, Young Mi
    Roh, Yong Ho
    Nam, Seung-Hyun
    Kim, Bong-Seog
    [J]. LUNG CANCER, 2010, 68 (02) : 248 - 252
  • [8] Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Yoshimura, Naruo
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenoir
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Kodama, Toyoki
    Ichimaru, Yukikazu
    Yana, Takashi
    Hirata, Kazuto
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 371 - 375
  • [9] Docetaxel-carboplatin chemotherapy in combination with cetuximab in patients with locally advanced or metastasized non-small cell lung cancer (NSCLC): Interim results of the nonrandomized phase II study TaxErb
    Fischer, J. R.
    Griesinger, F.
    Fink, T.
    Buchholz, E.
    Salm, T.
    Marseille, A.
    Wolf, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263